![Orlando Oliveira](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Orlando Oliveira
Vorstandsvorsitzender bei
SANTHERA PHARMACEUTICALS HOLDING AG
Profil
Orlando Oliveira is currently Chief Executive Officer at Santhera Pharmaceuticals Holding AG since 2026 and Director at Oncoinvent ASA since 2024.
Former positions include Director at Oncoinvent ASA (Old), VP-Europe & International Operations at Cubist Pharmaceuticals LLC from 2014 to 2015, Senior Vice President & GM-International at Tesaro, Inc. from 2015 to 2019, Senior Vice President & GM-International at Agios Pharmaceuticals, Inc. from 2019 to 2021, Senior Vice President & Head-International at Mirati Therapeutics, Inc. from 2022 to 2024, and Chief Commercial Officer at Zenas BioPharma, Inc. Education includes undergraduate and graduate degrees from the University of Coimbra and a graduate degree from ISCTE-Instituto Universitário de Lisboa.
Aktive Positionen von Orlando Oliveira
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCOINVENT ASA | Direktor/Vorstandsmitglied | 01.01.2024 |
| SANTHERA PHARMACEUTICALS HOLDING AG | Vorstandsvorsitzender | 15.07.2026 |
Ehemalige bekannte Positionen von Orlando Oliveira
| Unternehmen | Position | Ende |
|---|---|---|
| MIRATI THERAPEUTICS | Corporate Officer/Principal | 01.04.2024 |
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2021 |
| TESARO INC | Corporate Officer/Principal | 01.06.2019 |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 01.04.2015 |
Oncoinvent AS
 Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Direktor/Vorstandsmitglied | - |
Ausbildung von Orlando Oliveira
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
ISCTE-Instituto Universitário de Lisboa
 ISCTE-Instituto Universitário de Lisboa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Coimbra
 University of Coimbra Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BerGenBio ASA
 BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
